David Francisco insider trades

Open-market stock purchases and sales by David Francisco, Chief Financial Officer at Organogenesis Holdings Inc, from SEC Form 4 filings since Feb 15, 2021.

Recent trades

DateStockTradeValue
Feb 18, 2026ORGO Organogenesis Holdings IncSold (not open market)$56.4K
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 18, 2026ORGO Organogenesis Holdings IncSold (not open market)$55.8K
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$14.5K
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$79.9K
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$49.9K
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$51.4K

Companies traded

  • ORGO Organogenesis Holdings Inc: other filings, last Feb 18, 2026

Get free alerts when David Francisco files a new trade →